Murphy-Beiner A
Imperial College London, London, UK.
ArticleDMT
A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.
ArticlePsychedelics
Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences.
ArticlePsilocybin
Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.
ArticlePsychedelics
Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs.
ArticlePsilocybin
When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.
ArticlePsychedelics
Extended difficulties following the use of psychedelic drugs: A mixed methods study.
ArticlePsilocybin
Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.
ArticlePsychedelics
ARC: a framework for access, reciprocity and conduct in psychedelic therapies.
ArticlePsilocybin